Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 2,147 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
RUBIN, TURNBULL & ASSOCIATES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $150,000.00 income
Pharmacy, Health Issues
View →
Q1
DA VINCI GROUP for PROCARE, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Pharmacy
View →
Q1
DA VINCI GROUP for BOESEN & SNOW, LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $10,000.00 income
Pharmacy
View →
Q1
VAN SCOYOC ASSOCIATES for QUVA PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
RUBIN, TURNBULL & ASSOCIATES for PHRMA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $90,000.00 income
Pharmacy, Health Issues
View →
Q1
RUBIN, TURNBULL & ASSOCIATES for USANTIBIOTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · $90,000.00 income
Pharmacy
View →
Q1
VAN SCOYOC ASSOCIATES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
S-3 GROUP for GOODRX
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q1
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy, Trade (domestic/foreign)
View →
Q1
LMH STRATEGIC SOLUTIONS for TRAVERE THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · $30,000.00 income
Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for SAVARA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q1
LMH STRATEGIC SOLUTIONS for REGENXBIO INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
4T
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $50,000.00 income
Pharmacy, Health Issues
View →
Q1
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Pharmacy
View →
4T
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
CORNERSTONE GOVERNMENT AFFAIRS, INC. for DALLAS COUNTY HOSPITAL DISTRICT D/B/A PARKLAND HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for ARDELYX, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income
Health Issues, Pharmacy
View →
Q1
ARENTFOX SCHIFF LLP for PHARVARIS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income
Medicare/Medicaid, Pharmacy
View →
1@
BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate
Medicare/Medicaid, Pharmacy
View →
1T
BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate
Medicare/Medicaid, Pharmacy
View →
Q1
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Medicare/Medicaid, Budget/Appropriations, Education, Insurance
View →
Q1
VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · Senate · $30,000.00 income
Consumer Issues/Safety/Products, Pharmacy
View →
Previous Page 25 of 86 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem